San Diego, CA, United States of America

Kimberly Elizabeth Fultz

This inventor holds 7 USPTO granted patents and 4 published patent applications, plus 2 CIPO patents and 4 EPO patents. Top assignee: Signal Pharmaceuticals, Inc.. Active years: 2012-2018.

IDiyas Innovation Intelligence. (2026). Inventor Profile: Kimberly Elizabeth Fultz. Retrieved from https://idiyas.com/inventor/kimberly-elizabeth-fultz

Data source: USPTO (United States Patent and Trademark Office) public patent records. Weekly synchronization. How IDiyas builds this profile

USPTO Granted Patents = 7 

% Patents Active = 100.0

 

 

Average Co-Inventor Count = 6.0

ph-index = 5

Forward Citations = 120(Granted Patents)


Company Filing History:


Years Active: 2012-2018

Loading Chart...
Loading Chart...
Loading Chart...
7 patents (USPTO):Explore Patents

Title: Innovator Spotlight: Kimberly Elizabeth Fultz

Introduction

Kimberly Elizabeth Fultz is a notable inventor based in San Diego, California, recognized for her significant contributions to cancer treatment through her innovative research. With a total of seven patents to her name, Fultz is at the forefront of developing new therapeutic methods aimed at combating cancer, utilizing her expertise in pharmacology and biochemistry.

Latest Patents

Among her latest patents, Fultz has developed methods for treating cancer using TOR kinase inhibitor combination therapy, specifically through the administration of substituted pyrazino[2,3-b]pyrazines. This innovative approach involves providing an effective amount of a TOR kinase inhibitor along with a second active agent to patients diagnosed with cancer. This dual therapy aims to enhance the efficacy of cancer treatment, offering hope to those affected by this disease.

Career Highlights

Fultz's career is distinguished by her commitment to researching and developing advanced treatment solutions in oncology. Working at Signal Pharmaceuticals, Inc., she collaborates with a dedicated team to push the boundaries of cancer research and therapeutic strategies. Her work emphasizes the importance of innovative thinking in the pharmaceutical industry, where new methodologies can lead to breakthroughs in patient care.

Collaborations

Fultz has collaborated with notable colleagues such as Weiming Xu and Deborah Mortensen, contributing to a dynamic environment of shared knowledge and expertise. These partnerships enhance the research and development efforts at Signal Pharmaceuticals, Inc., allowing for a synergistic approach to tackling complex health issues like cancer.

Conclusion

In summary, Kimberly Elizabeth Fultz exemplifies the impact of innovation in the medical field. Her patents, particularly in cancer treatment methodologies, underscore the vital role of inventors in advancing healthcare. As she continues her work at Signal Pharmaceuticals, Inc., Fultz remains a key figure in the pursuit of effective cancer therapies, inspiring future generations of scientists and researchers.

Profile summary based on public USPTO records.
Data Sources: USPTO Patent Grant XML, Patent Center, EPO & CIPO • Normalized by IDiyas Innovation Graph. Methodology & provenance architecturePlease report any incorrect information to [email protected]
Loading…